8 terminated. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Terminated 8 |
Follow Embolism: new trials by email Literature Review of Embolism trials Research Report on Embolism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test. Standard Enoxaparin 40 mg once-daily before randomization, Standard Enoxaparin 40 mg once-daily after randomization, Escalated Enoxaparin 30 mg twice-daily after randomization - Venous Thromboembolism | Phase 4 | Terminated | Pirogov Russian National Research Medical University | 9 | 2021-03-01 | 2025-01-07 |
| Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism TNKase, Placebo, Enoxaparin - Pulmonary Embolism, COVID | Phase 4 | Terminated | Cedars-Sinai Medical Center | 2 | 2020-09-08 | 2021-10-26 |
| Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism Alteplase, Unfractionated heparin, Placebo - Pulmonary Embolism With Acute Cor Pulmonale, Pulmonary Embolism | Phase 4 | Terminated | Victor Tapson, MD | 4 | 2019-07-25 | 2021-06-11 |
| PREvention of VENous ThromboEmbolism Following Radical Prostatectomy Subcutaneous Heparin - Prostate Cancer, Venous Thromboembolism | Phase 4 | Terminated | Johns Hopkins University | 501 | 2017-07-01 | 2020-08-05 |
| Low Molecular Weight Heparin for 72 Hours Followed by Dabigatran for Acute Intermediate-Risk Pulmonary Embolism. Dabigatran - Pulmonary Embolism | Phase 4 | Terminated | Prof. Stavros Konstantinides, MD | 400 | 2016-01-01 | 2020-02-17 |
| XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis rivaroxaban, warfarin - Pulmonary Embolism, Venous Thrombosis | Phase 4 | Terminated | Susan Smyth | 10 | 2015-07-01 | 2018-09-27 |
| Multicenter, Nonrandomized, Prospective Study of Pulmonary Embolism Removal With the AngioJet 6F Ultra System AngioJet Ultra PE Thrombectomy System - Pulmonary Embolism | Phase 4 | Terminated | Boston Scientific Corporation | 7 | 2013-01-01 | 2018-12-05 |
| Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk Home Monitoring Guided OAC, Physician-Directed OAC - Atrial Fibrillation, Atrial Flutter | Phase 4 | Terminated | Biotronik, Inc. | 2718 | 2008-02-01 | 2017-12-05 |
Pulmonary Embolism (7) · Venous Thrombosis (3) · Venous Thromboembolism (2) · Atrial Fibrillation (1) · Atrial Flutter (1) · Focal cortical dysplasia of Taylor (1) · Heart Failure (1) · Prostatic Neoplasms (1) · Stroke (1) · Ventricular Dysfunction, Right (1)
Cardiovascular Diseases (8) · Embolism and Thrombosis (8) · Vascular Diseases (8) · Lung Diseases (7) · Respiratory Tract Diseases (7) · Thrombosis (3) · Heart Diseases (2) · Thromboembolism (2) · Arrhythmias, Cardiac (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Genital Diseases (1) · Genital Diseases, Male (1)
Heparin (2) · Dabigatran (1) · Enoxaparin (1) · Heparin, Low-Molecular-Weight (1) · Rivaroxaban (1) · Tenecteplase (1) · Tissue Plasminogen Activator (1) · Warfarin (1) · apixaban (1) · enoxaparin sodium (1)
Biotronik, Inc. (1) · Boston Scientific Corporation (1) · Cedars-Sinai Medical Center (1) · Johns Hopkins University (1) · Pirogov Russian National Research Medical University (1) · Prof. Stavros Konstantinides, MD (1) · Susan Smyth (1) · Victor Tapson, MD (1)
United States (4) · Germany (3) · Australia (1) · Canada (1) · Denmark (1) · Italy (1) · Portugal (1) · Russia (1) · Switzerland (1) · United Kingdom (1)
Aaron S Weinberg, MD (1) · John Ip, M.D. (1) · Jonathan L Halperin, M.D. (1) · Kirill Lobastov, PhD (1) · Mohamad E Allaf, MD (1) · Nils Kucher, Prof Dr Med (1) · Stavros Konstantinides, Prof., MD (1) · Susan S Smyth, MD PhD (1) · Victor E Tapson, MD (1) · Victor F Tapson, MD (1)
PMID 25908774, PMID 30352714, PMID 31643128, PMID 32444264, PMID 34363769